-+ 0.00%
-+ 0.00%
-+ 0.00%

NervGen Pharma Q3 EPS $(0.04) Beats $(0.12) Estimate

Benzinga·11/16/2026 13:58:58
Listen to the news
NervGen Pharma (NASDAQ:NGEN) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.12) by 66.67 percent.